209
Participants
Start Date
July 31, 2010
Primary Completion Date
November 30, 2011
Study Completion Date
February 29, 2012
PGL4001, placebo
PGL4001 10mg once daily (oral tablets) for 3 months followed by a period of 10 days of placebo (oral tablets).
PGL4001, progestin
PGL4001 10mg once daily (oral tablets) for 3 months followed by a period of 10 days of progestin Norethisterone acetate 10mg once daily (oral tablets).
Medical University Vienna, department of obstetrics and gynecology, Vienna
Cliniques Universitaires Saint-Luc, Brussels
CHR de la citadelle, Liège
Cliniques Universitaires UCL de Mont-Godinne, Yvoir
Medical University Graz, department of obstetrics and gynecology, Graz
Hospital General de Ciudad Real Gynecology, Ciudad Real
Hospital Universitario de Guadalajara Consultas de Ginecología (Planta 0), Guadalajara
Clinica Ginecologica CEOGA, departamento de Ginecologia, Lugo
Private pratice, Madrid
Hospital universitario 12 de Octubre, departamento de ginecologia, Madrid
CHIP, Málaga
Prywatna Klinika Polozniczo-Ginekologiczna, Bialystok
INVICTA Sp. Z o.o., Gdansk
Private Practice, Katowice
Private Practice, Lodz
Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie Klinika Ginekologii Onkologicznej i Ginekologii, Lublin
Private Practice, Warsaw
Private Practice, Warsaw
Centralny Szpital Kliniczny MSWiA w Warszawie, Klinika Poloznictwa, Chorob Kobiecych i Ginekologii Onkologicznej, Warsaw
Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wrocławiu, I Katedra i Klinika Ginekologii i Położnictwa, Wroclaw
Institut Universitari Dexeus Departamento de Ginecología, Barcelona
Hospital Universitario Hebron, gynecology department, Barcelona
Hospital Clinic i provincial de Barcelona, gynecology department, Barcelona
Lead Sponsor
PregLem SA
INDUSTRY